CREDIT AGREEMENT Dated as of October 6, 2017 amongCredit Agreement • February 27th, 2018 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 27th, 2018 Company Industry JurisdictionThis CREDIT AGREEMENT (“Agreement”) is entered into as of October 6, 2017, among QUIDEL CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
AGREEMENT RE: CHANGE IN CONTROLChange in Control Agreement • February 27th, 2018 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 27th, 2018 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 16, 2017 and is entered into by and between Ratan S. Borkar (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).